 mobihealthnews |
iSonea rapidly approaches commercialisation, targets US$16 billion asthma market
Proactive Investors USA & Canada iSonea (ASX: ISN) is preparing to roll out a number of its asthma products over the next 24 months after entering its first formal partnership with telecommunications company Qualcomm Life for the development of a mobile asthma monitoring platform. iSonea to Develop New Asthma Mobile Health Technology Based on Qualcomm 2net Hub Qualcomm Life, iSonea to offer mobile asthma monitor iSonea gains partner to develop new mobile asthma monitoring system |
View full post on asthma – Google News